Dual Biologic Therapy in Patients with Rheumatoid Arthritis and Psoriatic Arthritis

Treatment with biological agents has become standard of care in treatment of immune-mediated diseases (IMD), including rheumatoid arthritis and psoriatic arthritis. Yet, a significant proportion of patients experience loss of response to biologics, need treatment escalation, or develop side effects....

Descripción completa

Detalles Bibliográficos
Autores principales: Furer, Victoria, Elkayam, Ori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rambam Health Care Campus 2023
Materias:
Special Issue on Rheumatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147400/
https://www.ncbi.nlm.nih.gov/pubmed/37116059
http://dx.doi.org/10.5041/RMMJ.10494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147400/
https://www.ncbi.nlm.nih.gov/pubmed/37116059
http://dx.doi.org/10.5041/RMMJ.10494

Ejemplares similares